SCHEMBL5850758

SCHEMBL5850758

Cc1cc(CC(C)c2oc(-c3ccc(C(F)(F)F)cc3)nc2C(C)C)ccc1OCC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 19/20 0.59
PPARA Q07869 5/20 0.59
PPARG P37231 3/20 0.56
PTPN1 P18031 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5850619 0.92 PPARD (0.49) PPARDPPARAPPARGPTPN1
SCHEMBL5852182 0.77 PPARD (0.44) PPARDPPARAPPARGPTPN1
SCHEMBL5850942 0.77 PPARD (0.59) PPARDPPARAPPARG
SCHEMBL5217676 0.76 PPARD (0.66) PPARDPPARAPPARGPTPN1
SCHEMBL5850957 0.75 PPARA (0.50) PPARDPPARAPPARG
SCHEMBL12801426 0.75 PPARD (0.73) PPARDPPARAPPARG
SCHEMBL5215875 0.75 PPARD (0.63) PPARDPPARAPPARG
SCHEMBL5218962 0.75 PPARD (0.63) PPARDPPARAPPARG
SCHEMBL5221374 0.75 PPARD (0.63) PPARDPPARAPPARG
SCHEMBL5221031 0.74 PPARD (0.52) PPARDPPARAPPARGPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7153878-B2 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2006-12-26 US disclosed
US-20050107449-A1 Peroxisome proliferator activated receptor modulators ELILILLY AND COMPANY 2005-05-19 US disclosed
EP-1480640-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2004-12-01 EP disclosed
WO-2003072100-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107449-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD PPARD 3/4885PPARA 2/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.